March 17, 2016 / 10:45 PM / a year ago

BRIEF-Health canada says four Canadian clinical trials, involving cancer medicine zydelig (idelalisib) in combination with other cancer medicines, being stopped

1 Min Read

March 17 (Reuters) - Gilead Sciences Inc

* International clinical trials, including trials in Canada, are being stopped due to serious adverse events with the drug zydelig, in combination with other cancer drugs

* Is also conducting a review of drug zydelig and will take appropriate next steps as needed

* Says three additional trials will be amended by implementing added measures to protect participants

* Four Canadian clinical trials, involving cancer medicine zydelig (idelalisib) in combination with other cancer medicines, being stopped Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below